SCHEMBL25787124

SCHEMBL25787124

CC(C)CCO[PH](C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26724876 0.85 LMNA (0.35)
SCHEMBL26724878 0.83 LMNA (0.39)
SCHEMBL8438207 0.82
SCHEMBL28002589 0.81 LMNA (0.37)
SCHEMBL4947867 0.81 ALDH1A1 (0.44)
SCHEMBL29091867 0.80 LMNA (0.36)
Butane SCHEMBL10594290 0.77 ALDH1A1 (0.37)
SCHEMBL28482449 0.75 ALDH1A1 (0.39)
SCHEMBL11757770 0.75 ALDH1A1 (0.39)
SCHEMBL11999098 0.73 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873291-B2 Quinoline cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2024-01-16 US disclosed
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 US disclosed
US-20230212148-A1 THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION GILEAD SCIENCES, INC. 2023-07-06 US disclosed